CIK 0001738021 · Non-accelerated filer<br>Smaller reporting company
Compass Therapeutics, Inc.
Sign in to watch- Ticker
- CMPX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-500-8099
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- Former names
- Olivia Ventures, Inc.
- Open-market buys, last 90 days
- $21,250
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$21,250. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-06 | ORBIMED ADVISORS LLC Director | Purchase | +10,200 | $1.63 | $17K | 14,510,319 |
| 2022-05-06 | GORDON CARL L Director | Purchase | +10,200 | $1.63 | $17K | 14,510,319 |
| 2021-11-04 | GORDON CARL L Director | Purchase | +1,785,715 | $3.50 | $6.3M | 14,500,119 |
| 2021-11-04 | GORDON CARL L Director | Purchase | +3,571,428 | $3.50 | $12.5M | 3,571,428 |
| 2021-11-04 | ORBIMED ADVISORS LLC Director | Purchase | +1,785,715 | $3.50 | $6.3M | 14,500,119 |
| 2021-11-04 | ORBIMED ADVISORS LLC Director | Purchase | +3,571,428 | $3.50 | $12.5M | 3,571,428 |
| 2020-06-19 | Sunderland Julie Director | Purchase | +289,118 | $5.00 | $1.4M | 2,502,025 |
| 2020-06-19 | Schuetz Thomas J. Chief Executive Officer | Purchase | +97,431 | $5.00 | $487K | 4,525,467 |
| 2020-06-19 | Ferneau Philip Director | Purchase | +64,066 | $5.00 | $320K | 2,348,976 |
| 2020-06-19 | Ferneau Philip Director | Purchase | +250,000 | $5.00 | $1.3M | 400,280 |
| 2020-06-19 | GORDON CARL L Director | Purchase | +1,455,132 | $5.00 | $7.3M | 12,714,404 |
| 2020-06-19 | ORBIMED ADVISORS LLC Director | Purchase | +1,455,132 | $5.00 | $7.3M | 12,714,404 |
Page 3 of 3 · 52 trades